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Glibenclamide prevents increased extracellular matrix formation induced by
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Giannico G, Cortes P, Baccora MH, Hassett C, Taube DW, Yee
J. Glibenclamide prevents increased extracellular matrix formation
induced by high glucose concentration in mesangial cells. Am J
Physiol Renal Physiol 292: F57–F65, 2007. First published August 8,
2006; doi:10.1152/ajprenal.00210.2006.—Other than stimulation of
cell contractility, little is known about the potential metabolic effects
induced by sulfonylureas, independently of insulin action. Previous
studies from our laboratory demonstrated complete abrogation of
glomerulosclerosis in an experimental model of type 1 diabetes
chronically (9 mo) treated with low-dose sulfonylureas (Biederman JI,
Vera E, Pankhaniya R, Hassett C, Giannico G, Yee J, Cortes P.
Kidney Int 67: 554 –565, 2005). Therefore, the effects of glibenclamide (Glib) on net collagen I, collagen IV, and fibronectin medium
net secretion and cell layer collagen I deposition were investigated in
mesangial cells continuously exposed to 25 mM glucose for 8 wk and
treated with predetermined increasing concentrations of Glib for the
same period. Clinically relevant concentrations (0.01 M) of Glib
fully suppressed the high glucose-enhanced accumulation of collagen
I, collagen IV, and fibronectin in the medium and inhibited collagen
I deposition in the cell layer. These effects occurred while transforming growth factor (TGF)-␤1 medium concentration remained elevated
and glucose uptake was increased to levels above those in 25 mM
glucose-incubated cultures. The decreased collagen I accumulation
occurred simultaneously with enhanced collagen I mRNA expression
in concert with marked suppression of plasminogen inhibitor type-1
(PAI-1) mRNA and protein expression. This strongly suggests an
accelerated matrix turnover favoring breakdown. Glib-induced effects
demonstrated a biphasic pattern, being absent or reversed in cells
treated with higher Glib concentrations (0.1 or 1 M). Therefore,
chronic Glib treatment at low concentrations markedly diminishes the
high glucose-induced enhanced accumulation of extracellular matrix
components by suppression of steady-state PAI-1 transcriptional activity. These results and those previously reported in vivo suggest that
long-term Glib treatment may prevent glomerulosclerosis in insulindeficient diabetes.
diabetic nephropathy; sulfonylureas; mesangial cells; ␣-endosulfine;
matrix catabolism; plasminogen inhibitor type-1
IN STUDYING THE CAUSES OF diabetic glomerulosclerosis, we and
others have emphasized the altered metabolic activity of mesangial cells. The first and most characteristic glomerular lesion
of diabetes is mesangial deposition of extracellular matrix that
precedes interstitial disease (18, 45). Thus, it is the exaggerated
mesangial cell (MC) formation of matrix that has been generally considered central to the pathogenesis of diabetic nephropathy. Numerous studies have demonstrated that MC, exposed
to high glucose concentration (HG) in tissue culture, synthesize, independently of associated changes in osmolarity, in-
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creased amounts of matrix material that accumulates in the
culture medium (19). Based on these findings, it has been
widely accepted that hyperglycemia is a crucial factor in the
increased deposition of matrix and the genesis of mesangial
expansion and glomerulosclerosis in diabetes.
We have recently described the complete prevention of
glomerulosclerosis and increased albuminuria in a model of
insulin-deficient diabetes by the administration of sulfonylureas (5). This effect occurred at dosages equivalent to those
administered in humans and in the presence of unabated
hyperglycemia and unaltered renal hypertrophy and hyperfunction. In support of a unique glomerular action of sulfonylureas,
we have demonstrated the presence of all the needed components for the functionality of an endogenous sulfonylurea
system in MC and glomeruli (2, 48).
The known site of action of sulfonylureas is the ATPsensitive K⫹ channels (KATP). The plasma membrane KATP of
pancreatic ␤ cells has been the most extensively studied and is
considered the “classic” KATP (13). Classic KATP consist of
two structurally unrelated components: a potassium pore subunit and a sulfonylurea receptor (SUR) subunit. KATP have
been described in numerous cell types, including cardiomyocytes, skeletal muscle, and vascular smooth muscle cells (7). In
these tissues, they control cell contractility and organ functions
related to blood flow regulation (50). Pharmacological studies
have also demonstrated a diversity of KATP among various
tissues according to their affinity for sulfonylureas and sensitivity to K⫹ channel openers (17). These heterogeneous properties and functional diversity of KATP are based on unique
combinations of Kir6.x and SUR isoforms and also according
to their cellular distribution.
We have recently demonstrated the presence of a functional
rat mesangial KATP containing a unique SUR (2, 48). MC
membranes demonstrate specific binding of the sulfonylurea
glibenclamide (Glib), and following exposure to it, there is
increased intracellular Ca2⫹ concentration and intense MC
contraction (2). Furthermore, a rat mesangial SUR2 splice
variant was identified (48), mcSUR2B, which shares identity
with the smooth muscle-type rSUR2B also expressed in MC.
In addition to specific receptors, we have also demonstrated
gene and protein expression of the endogenous counterpart of
sulfonylureas, ␣-endosulfine, in MC in tissue culture and
glomeruli in situ (52). Endosulfines are members of a highly
conserved family of cAMP-regulated phosphoproteins (ARPP)
(14, 40). The structure of ␣-endosulfine, encoded by the ENSA
gene, has been well characterized and found to be ubiquitously
expressed in many tissues (25). Although ␣-endosulfine has
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been identified as a putative endogenous ligand for KATP
channels, its physiological role remains largely unknown.
Beyond their actions on insulin secretion and cell contractility, little is known regarding direct metabolic effects of
sulfonylureas. Because of the extensive expression of SUR in
multiple tissues, it may be anticipated that sulfonylureas are
capable of inducing metabolic changes other than those attributable to insulin action. Independently of insulin, sulfonylureas
augment glucose utilization in adipocytes and myocytes in
tissue culture by increasing the expression and activity of the
GLUT1 glucose transporter (15, 35). Motivated by these findings, we investigated the effects of the sulfonylurea tolazamide
on glucose uptake and matrix synthesis in a MC line in tissue
culture (9). In cells briefly treated with high (millimolar)
concentrations of tolazamide, increases in glucose uptake,
transforming growth factor (TGF)-␤1 secretion, and matrix
accumulation were delineated, suggesting that this drug could
aggravate diabetic glomerulosclerosis. Therefore, because
these initial in vitro observations were contradictory to our
recent findings in vivo, the present study was undertaken.
To ascertain a more relevant in vitro correlate to the setting
of glomerulosclerosis occurring only after long-standing diabetes, studies on extracellular matrix metabolism were carried
out in primary MC chronically exposed to HG. In addition,
these cells were treated with concentrations of Glib within the
nanomolar therapeutic range common in humans (41). Subsequently, it was demonstrated that under these conditions, low
concentrations of Glib inhibited extracellular matrix accumulation.
MATERIALS AND METHODS

Materials. Tissue culture, 75-cm2 flasks, and Falcon six-well plates
were from Corning (Corning, NY) and Becton Dickinson (Lincoln
Park, NJ), respectively. RPMI tissue culture medium 1640 and fetal
bovine serum (FBS) where obtained from GIBCO BRL (Grand Island,
NY). Polyclonal goat anti-rat (␣1, ␣2) collagen IV (capture antibody),
anti-rat type IV (␣2) collagen, and goat anti-mouse alkaline phosphatase-conjugated antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA), Chemicon (Temecula, CA), and Bethyl
Laboratories (Montgomery, TX), respectively. Polyclonal rabbit antirat collagen I antibody and alkaline phosphatase-conjugated goat
anti-rabbit IgG were purchased from Chemicon and ICN Pharmaceuticals (Aurora, OH), respectively. Anti-rat fibronectin antibody was

obtained from GIBCO BRL. Rat tail collagen type 1 and mouse
collagen type IV (Upstate Biotechnology, Lake Placid, NY) or purified fibronectin (GIBCO) were used as standards. Fluorescein diphosphate and DAPI nucleic acid stain were from Molecular Probes
(Eugene, OR). 2-Deoxy-D[14C(U)]glucose (323 mCi/mmol) was obtained from DuPont NEN (Boston, MA).
Cell culture. Primary cultures of MC were obtained from outgrowths of isolated glomeruli from Munich-Wistar rats (48). Cells
were grown in RPMI medium 1640, pH 7.4, containing 5 mM
glucose, 2 mM L-glutamine, 23.8 mM NaHCO3, 15% FBS, 5 U/ml
penicillin G, and 5 U/ml streptomycin. Cells were identified according
to their stellate appearance, formation of cell hillocks in postconfluent
cultures, expression of vimentin and ␣-smooth muscle actin but not
cytokeratin, and ability to grow in medium containing D-valine. Cells
at passages 3– 6 at the initiation of the experiments were used. Eight
weeks before the termination of the experiments, the medium in the
experimental group was changed to a similar one containing 25 mM
glucose and predetermined amounts of Glib, while the control group was
continuously grown in 5 mM glucose. At the end of the experimental
period, the last cell passage was in six-well culture plates, seeded at 40 ⫻
103 cells/well. Except where indicated, 48 h before the end of the
experiments, experimental and control media were changed to media of
the same composition but containing 1% FBS and 210 M sodium
ascorbate. Cultures were studied when 80 –90% confluent.
ELISA. The concentration of collagen I, collagen IV, and fibronectin in the 48-h conditioned media was determined by an indirect,
antibody sandwich ELISA (26) using an alkaline phosphatase-pnitrophenylphosphate chromogenic system. Purified rat collagen type
I (1–2,000 ng/well), mouse collagen type IV (32–2,000 ng/well), and
rat fibronectin, (0.5–500 ng/well) were used as standards. Unknowns
and standards were diluted in the same medium used in tissue culture.
All samples were tested in triplicate. Color intensity was measured
with a Titertek Multiscan MCC/340 (Flow Laboratories, McLean,
VA), and the results were analyzed using curve-fitting software
(Interactive Microware, State College, PA). The concentration of total
TGF-␤1 and rat plasminogen inhibitor type-1 (PAI-1) in aliquots of
conditioned media was determined using commercially available
ELISA kits (for TGF-␤1: Quantikine R&D Laboratories, Minneapolis, MN; for PAI-1: Aniara, Mason, OH) according to the manufacturer’s instructions. The PAI-1 assay reacts with latent, active, and
inactive PAI-1. Results were factored by number of cells according to
DNA content in the cell layer of the corresponding sample.
ELISA for adherent cells (cell-ELISA). The cell layer-associated
collagen I was measured by an innovative strategy based on the
indirect cellular ELISA. Cells were plated at 5,000 cells/well in
96-well Falcon 3945 Microtest (BD Biosciences, Franklin Lakes, NJ)

Table 1. Primers, probes, and experimentally determined optimal annealing temperature used in duplex analysis
with ␤-actin as a houskeeping gene
␤-Actin

PAI-1

␣1(I)Collagen

Forward
Primer

ACCCACACTGTGCCCA
TCTA

CCATCTCCGTGCCCATG
AT

GCCCCTCTGGAGCTTCT
G

Reverse
Primer

GGCCATCTCTTGCTCG
AA

GTCATGTTGCTCTTCCA
TTGTCT

AGACTTCTCTTGAGGTG
GCTGA

Donor
Probe

GCCACGCTCGGTCAG
GATCTTCAT X
LC705

GCTGAGGGTTTCGCCGT
GGTAG X
LC640

CCAGGGAGACCGTTGA
GTCCATCTTT X
LC640

Acceptor
Probe

AGGTAGTCTGTCAGGT
CCCGGCCA P

CAGTTCCAGGATGTCGT
ACTCGTGC P

CCAGGAGAACCAGCAG
AGCCAGG P

57°C

58°C

TA
PAI-1, plasminogen inhibitor type-1; TA, annealing temperature.
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and fixed in 3.7% paraformaldehyde in PBS at predetermined intervals between 24 and 96 h. After blocking with 3% fat-free dry milk in
PBS, samples were incubated at 4°C overnight with rat anti-collagen
I as the primary antibody. Following washing of the wells, samples
were successively incubated for 3 h at 4°C with phosphatase-conjugated goat anti-rabbit IgG, as the secondary antibody, and for 15–30
min in 4 M fluorescein diphosphate. Fluorescence was read at
485-nm excitation/527-nm emission in a Fluoroskan, Ascent FL
(Thermolabs Systems, Franklin, MA) microplate reader. Finally, after
washing of the wells, samples were incubated with 14.3 M of the
DNA-binding DAPI in PBS for 30 min for specific staining of nuclei,
washed, and placed in PBS, and read at 355-nm excitation/460-nm
emission. Fluorescein and DAPI fluorescence was compared with that
obtained in standard curves set up within the same plate using
0.01– 0.62 g/l collagen I and 5 ⫻ 103-5 ⫻ 104 cells/well, respectively. Results were expressed as micrograms collagen I per 104 cells.
DNA content. Following removal of media, cell layers were rinsed
twice with ice-cold PBS and cell layers were scraped in a 10 mM
sodium phosphate lysis buffer, pH 7.5, containing 150 mM NaCl, 2
mM EDTA, 1% Igepal, and 1% sodium deoxycholate. Samples were
homogenized in the cold in a glass-glass tissue grinder with five
strokes at 10 rpm and centrifuged at 26,000 g for 20 min at 4°C. The
resulting supernatants were used for the measurement of DNA in
96-well plates by a fluorescence method using the PicoGreen dsDNA
kit (Molecular Probes) according to the manufacturer’s directions.
Fluorescence was determined at 480-nm excitation/520-nm emission.
DNA standards yielded linear regressions between 5 and 200 ng/ml
DNA. Analyses were done using a Fluoroskan Ascent FL microplate
reader (Thermo Electron).
Quantitative, real-time gene expression. Total RNA was extracted
from cell layers using RNeasy minikits (Qiagen, Valencia, CA) after
DNAse treatment. The approach for the measurement of gene expression
was a one-step RT-PCR with specific FRET probes using a multiplex
mode (gene of interest and housekeeping gene expression measured
simultaneously in the same reaction capillary) in a LightCycler (Roche
Molecular Biochemicals, Mannheim, Germany). Primers and probes for
␣1(I)collagen and PAI-1 quantification were obtained from Roche Pharmaceuticals (Indianapolis, IN) and TIB Molbiol LCC (Adelphia, NJ),
respectively. Reactions were done using the QuantiTect Probe (Qiagen)
and SuperSciptIII Platinum (Invitrogen, Carlsbad, CA) kits for ␣1(I)collagen and PAI-1, respectively. Analyses were done in triplicate. As
reference we used ␤-actin expression because recent published studies
from our laboratory have demonstrated this gene to be one of the most
stable in MC cultured in HG conditions and in isolated glomeruli of
diabetic rats (4). In addition, since our previous studies demonstrated that
total RNA was also a reliable reference for gene expression in cultured
MC (4), the stability of ␤-actin expression was also documented by
factoring for the sample’s RNA content. Total RNA was quantified using
a RiboGreen RNA kit (Molecular Probes) following the manufacturer’s
instructions. The primers, probes, and experimentally determined optimal
annealing temperature for the multiplex conditions used are presented in
Table 1.
Glucose transport. The initial rate of glucose transport was measured as in our prior studies (9). In brief, the 3-min transporter-specific
uptake of 2-deoxy-D[14C(U)]glucose was measured in the cell layer of
MC cultured to confluency. The uptake rate was determined using 10
M 2-deoxy-D-glucose and 1 Ci/ml 2-deoxy-D[14C(U)]glucose in
Dulbecco’s buffer. Incubations were terminated by the addition of
ice-cold PBS containing 0.3 mM phloretin and 20 M unlabeled
2-deoxy-D-glucose. The amount of extracellular radioactivity present
in the sample and the transporter-independent glucose uptake were
determined in parallel culture wells in which incubation with radiolabeled 2-deoxy-D-glucose was carried out in the presence of cytochalasin B, an inhibitor of glucose transporters. Results were expressed as
picomoles 2-deoxyglucose uptake per minute per unit protein in the 1
N NaOH-treated cell layer. Total protein was measured by the
Folin-Ciocalteau phenol reagent method.
AJP-Renal Physiol • VOL
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Statistical analysis. Statistical analyses were carried out using StatView 5.0.1 software (Abacus Concepts, Berkeley, CA). Results are
expressed as means ⫾ SE. Results were analyzed by analysis of variance.
If a significant difference was found among groups, between group
comparisons were made with post hoc testing with Fisher’s protected
least significant difference. Statistical significance was set at the 5% level.
RESULTS

Effects of Glib on the extracellular matrix accumulation
induced by HG concentration. The long-term effects of HG
concentration on MC matrix formation and their modification
by Glib were studied in cultures treated with increasing concentrations of the sulfonylurea. The accumulation of collagen I
was measured first since this is the predominant form synthesized by MC in tissue culture (1, 38). HG caused a significant
40% increase in the net accumulation of collagen I into

Fig. 1. Collagen I and transforming growth factor (TGF)-␤1 medium accumulation in primary mesangial cell cultures chronically exposed to high
glucose concentration and treated with glibenclamide. Mesangial cells were
placed in a medium containing 25 mM glucose and increasing concentrations
of glibenclamide for 8 wk. Control mesangial cells were continuously grown
in 5 mM glucose. At the end of the experiment, collagen I and total TGF-␤1
concentrations were measured in the 48-h conditioned media of 90% confluent
cultures by ELISA. Results were factored by DNA in the cell layer, measured
by a fluorescence-based method. Values are means ⫾ SE.
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the medium over the values in 5 mM glucose-grown controls
(Fig. 1). Continuous treatment with 0.01 M Glib over the
entire period of exposure to HG totally prevented this alteration. Furthermore, in these Glib-treated cells collagen I net
accumulation was significantly lower than in 5 mM glucosegrown controls. However, contrary to what was anticipated,
increasing the medium concentration of Glib by 10-fold or
higher abolished its inhibitory effect (Fig. 1). Glib treatment
for periods between 6 and 10 wk or in the presence of 20 mM
glucose concentration yielded similar results.
To investigate whether the changes induced in extracellular
matrix formation by low concentrations of Glib were due to
inhibition of TGF-␤1 secretion, the concentration of this
growth factor was measured in the same conditioned media in
which collagen I accumulation was quantified (Fig. 1). TGF-␤1
concentration was elevated in 25 mM glucose cultures without
the demonstration of any significant change with Glib treatment at any of the concentrations tested. As shown in Fig. 1,
there was no relationship between collagen I accumulation and
medium TGF-␤1 concentration in Glib-treated cultures.
Fibronectin media net accumulation in cultures chronically
exposed to HG and long-term treatment with Glib demonstrated changes similar to those for collagen I. Thus the 39%
increase in media fibronectin induced by 25 mM glucose was
fully prevented by 0.01 M Glib, although the resulting values
were not lower than those in 5 mM glucose-grown controls
(Fig. 2). In addition, 0.1 M Glib did not cause any amelioration of the 25 mM glucose enhancement in fibronectin
secretion.
The effects of Glib on collagen I accumulation were confirmed in six additional separate experiments. The combined
results obtained in these are presented in Fig. 3. These results
showed similar changes in collagen I accumulation induced by

Fig. 2. Fibronectin medium accumulation in rat mesangial cell cultures chronically exposed to high glucose concentration and treated with glibenclamide.
Mesangial cells were cultured and glibenclamide-treated as in Fig. 1. At the
end of the experiment, fibronectin concentration was measured in the 48-h
conditioned media by ELISA. Results were factored by cell layer DNA. Values
are means ⫾ SE.
AJP-Renal Physiol • VOL

Fig. 3. Collagen I medium accumulation in rat mesangial cell cultures chronically exposed to high glucose concentration and treated with the sulfonylurea
glibenclamide. Studies were carried out under the same conditions as in Fig. 1.
The combined data obtained in 6 separate experiments are presented with
results expressed as a percentage of the corresponding 5 mM glucose-incubated controls, with the total number of samples (n) indicated in each
experimental group. Values are means ⫾ SE.

Glib treatment in HG-incubated cells as those shown in Fig. 1.
In addition, 8-wk treatment with 0.01 M Glib in cells continuously grown in 5 mM glucose had no effect on media
collagen I net accumulation (Fig. 3).
Since initial experiments demonstrated that the quantity of
collagen I deposited on the cell layer gradually decreases with
increasing confluence of the cultures, the effect of Glib was
studied at different periods of growth in long-term HG-incubated cells. Results were similar to those observed in the
conditioned media. In cells cultured in 25 mM glucose, 0.01
M Glib significantly decreased collagen I deposition to levels
in 5 mM glucose controls at all periods between 2 and 4 days
(Fig. 4). However, in these 25 mM glucose-incubated cells, 1
M Glib concentration did not induce any changes over the
same period of time. Contrary to the lower concentration, 1
M Glib transiently induced increased collagen deposition at
24 h of growth (Fig. 4).
To investigate whether changes in collagen I media accumulation were mediated by altered gene expression, cell layer
total RNA was quantitatively studied for ␣1(I)collagen expression under the same conditions as those in Figs. 1– 4. Collagen
I mRNA expression was upregulated by HG, as expected (Fig.
5). Unexpectedly, however, increasing Glib concentrations
resulted in changes in collagen I mRNA expression that were
the reverse of its effects on protein accumulation (Figs. 1 and
5). Thus 0.01 M Glib enhanced the level of collagen I mRNA
expression well above that induced by HG (21 vs. 69% over 5
mM controls), while the increased protein expression caused
by HG (40% over 5 mM controls) was significantly diminished
by Glib to values lower than controls (⫺36% of 5 mM control).
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Fig. 4. Cell layer deposition of collagen I during growth of rat mesangial cell
cultures chronically exposed to high glucose concentration and treated with
glibenclamide. Mesangial cells were seeded in 96-well plates (5,000 cells/well)
under the same experimental conditions as in Fig. 1. Separate sets of plates
were processed at determined time periods during exponential growth. At each
period, cell layers were fixed and cell layer-associated collagen I was measured
by ELISA in a fluorogenic reaction. The number of cells in each well was
assessed by reaction with the DNA-binding fluorescent dye DAPI. Results
were derived from separate collagen I and cell density standard curves. The
amount of collagen per well was factored by the corresponding number of cells
in the same well. Values are means ⫾ SE.

However, high Glib concentration did not alter the HG-enhanced collagen I mRNA expression (Fig. 5).
To corroborate the above, steady-state collagen mRNA expression was also studied in undisturbed cultures without
removal of FBS. In these experiments, differences between
groups in mRNA expression were similar to that in 48-h
serum-restricted cultures. However, the ␣1(I)collagen/␤-actin
ratio was markedly decreased in these non-serum-starved cultures. This was the result of suppressed ␤-actin mRNA expression during serum starvation as shown by a 58 – 65% decrease
in ␤-actin/total RNA ratio. Thus it is important to document
the stability of any housekeeping gene of choice, not only
among different groups within any given experiment but also
among different experiments when media composition is
changed during the experimental period.
Effects of Glib on changes in PAI-1 expression induced by
HG concentration. PAI-1 exerts powerful effects on extracellular matrix degradation and turnover in MC in culture (3).
These effects are mediated by inhibition of plasminogen activators and plasmin-induced extracellular matrix breakdown,
and the inactivation of metalloproteinases that enzymatically
cleave collagenous proteins. In addition, PAI-1 also enhances
renal fibrosis via stimulation of TGF-␤ activity (32). Therefore,
changes in PAI-1 expression were investigated as a possible
cause for the contraposing effects of Glib on collagen I gene
expression and protein accumulation.
The steady-state expression of PAI-1 mRNA was markedly
increased (3-fold) in MC chronically exposed to HG compared
with cells grown in 5 mM glucose concentration (Fig. 6).
Treatment of HG-incubated cells with low concentrations of
Glib fully reversed this increased expression to levels similar to
those in cells kept in normal glucose (Fig. 6). In contrast,
treatment with high Glib concentration induced an increased
PAI-1 mRNA expression that surpassed that shown in nontreated, 25 mM glucose-incubated cells (4.5-fold over 5 mM
glucose control) (Fig. 6).
To directly compare the effects of HG and Glib treatment on
PAI-1 and collagen protein accumulation, these were measured
in the same conditioned media in experiments carried out under

Fig. 5. Collagen gene expression in rat mesangial cell cultures chronically exposed to
high glucose concentration and treated with
glibenclamide. Expression of ␣1(I)collagen
was quantified in total RNA extracted from
cell layers of mesangial cells exposed to 5 or
25 mM glucose for 8 wk with or without
concomitant treatment with increasing concentrations of glibenclamide. Experimental
conditions were as in Figs. 1– 4. Gene expression was quantified by real-time RTPCR in a multiplex format. Results were
factored per ␤-actin expression. Since the
␤-actin-to-total RNA ratio is influenced by
reduced ␤-actin expression in serum-restricted cells (left), experiments were repeated in non-serum-starved cultures (15%
FBS; right). Values are means ⫾ SE.
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exposure to HG significantly exceeded that in previous studies
of MC in tissue culture. As further support of this clinical
relevance, the results obtained are in harmony with our previous observations regarding prevention of glomerulosclerosis in
insulin-deficient diabetic animals, chronically treated with Glib

Fig. 6. Plasminogen inhibitor type-1 (PAI-1) gene expression in rat mesangial
cell cultures chronically exposed to high glucose concentration and treated
with glibenclamide. Studies were conducted and measurements were carried
out as in Fig. 5. Cultures were not serum restricted. Values are means ⫾ SE.

identical conditions as in the studies above. As for the gene
expression, PAI-1 protein in HG-exposed cells was reduced by
treatment with low Glib concentration to levels similar to those
in 5 mM glucose control cells (Fig. 7). In addition, this
Glib-induced inhibition was not evident in high Glib concentration-treated cultures. The changes in PAI-1 protein expression induced by HG and different concentrations of Glib were
associated by parallel alterations in collagen IV and collagen I
protein accumulation (Fig. 7).
Transporter-specific glucose uptake in Glib-treated MC.
Because previous studies in mesangial and other cells demonstrated that short-term treatment with sulfonylureas may increase glucose uptake, thus enhancing collagen synthesis, the
effects of long-term treatment with increasing concentrations
of Glib on glucose uptake were investigated.
The initial rate of transporter-specific 2-deoxy-glucose uptake was determined in MC chronically exposed to 25 mM
glucose and in similar cells treated with increasing concentrations of Glib as in the studies above. Compared with 5 mM
glucose-grown controls, exposure to HG induced a modest
(9%) but significant stimulation of glucose uptake (Fig. 8).
Low Glib concentration treatment increased glucose uptake to
levels significantly above those in nontreated, HG-exposed
cells (14% over control). However, 1 M Glib did not alter the
uptake demonstrated in HG-exposed cells, while a 50-fold
higher Glib concentration significantly decreased glucose uptake to levels below those in 5 mM glucose controls (Fig. 8).
DISCUSSION

This study demonstrates, for the first time, the unanticipated
property for low concentrations of Glib to prevent the HGenhanced accumulation of extracellular matrix components in
MC. This effect occurred in the amount secreted in the incubation medium and in the quantity deposited in the cell layer.
The potential clinical significance of these observations results
from the experimental conditions used that mimic the longterm effects of uncontrolled hyperglycemia. The length of
AJP-Renal Physiol • VOL

Fig. 7. Collagen IV, collagen I, and PAI-1 protein medium accumulation in
primary mesangial cell cultures chronically exposed to high glucose concentration and treated with glibenclamide. Experimental conditions were similar to
those used in Figs. 1– 6. Quantitative analysis of collagen IV, collagen I, and
PAI-1 protein was carried out in the 48-h conditioned medium by ELISA as in
Fig. 1. Values are means ⫾ SE.
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Fig. 8. GLUT transport-specific 2-deoxyglucose uptake by primary cultures of
rat mesangial cells chronically exposed to high glucose concentration and
treated with glibenclamide. Experimental conditions were similar to those in
Figs. 1–7. Incorporation rates were corrected for transporter-independent
uptake as determined in parallel cultures incubated with 10 M cytochalasin B.
Protein-normalized incorporation rates are presented. Values are means ⫾ SE.

at a dosage that was therapeutically equivalent to those in
humans (5). In addition, the low Glib concentration used
during MC treatment in tissue culture is well within the clinical
range (peak plasma level after one 5-mg oral Glib dose is
0.09 – 0.6 M; daily therapeutic dosage generally is 2.5–20
mg) (41, 49).
Glib specifically interferes with the cell response to HG
concentration and does not affect the unstimulated, basal condition. This is evident by the lack of effect of 0.01 M Glib on
collagen I mRNA expression and collagen I protein accumulation in cells maintained in 5 mM glucose. That is, irrespective
of its actions on insulin secretion, Glib is not expected to
directly alter MC extracellular matrix metabolism under physiological circumstances.
Low Glib concentration modestly stimulated glucose uptake,
probably by increasing the expression of the GLUT1 glucose
transporter, as has been reported in other cells acutely treated
with Glib and other sulfonylureas (8, 15). However, the biological significance of this increased transport may be important. We have previously demonstrated the prime influence of
glucose transport as a regulator of the synthesis and accumulation rate of extracellular matrix (24). Thus this increased
glucose uptake may represent the stimulus for enhanced expression of collagen I mRNA and increased collagen I protein
accumulation rate demonstrated in this study.
In regard to the mechanism by which low Glib concentrations diminish HG-induced matrix accumulation, our data
strongly suggest that high turnover and increased matrix breakdown are involved. While collagen I gene expression may be
stimulated by increased glucose availability, there is a simultaneous repression of PAI-1 gene and protein expression,
indicative of an enhanced catabolic rate, fully counterbalancing
the increased synthetic activity. Thus, while Glib stimulates
glucose transport, it exerts a concomitant strong suppression of
PAI-1 transcriptional activity and/or enhanced PAI-1 mRNA
AJP-Renal Physiol • VOL
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degradation (23). The main candidate mediator of this effect is
an elevated cAMP level. Principally, the downregulation of
steady-state PAI-1 mRNA content by agents that stimulate
cAMP formation is a well-documented major regulatory mechanism (11, 23). Furthermore, sulfonylureas are known to activate adenylyl cyclase and inhibit the activity of phosphodiesterases, thus leading to an increase in cellular cAMP levels
(43).
PAI-1 expression plays an important role in the pathogenesis
of diabetic glomerulosclerosis (16). PAI-1 expression is upregulated by HG in MC in tissue culture and by diabetes in MC
in situ (21, 30, 33). Furthermore, PAI-1 activity has been
demonstrated to be a pathogenetic contributor to the development of nephropathy in experimental, insulin-deficient diabetes
(36). Thus PAI-1 is considered an important therapeutic target
in the prevention of progressive renal fibrosis (27).
Concerning the possible relationship between Glib and cytokines stimulated by HG, Glib suppression of net collagen I
accrual occurred in the setting of TGF-␤1 enhancement, suggesting that Glib interferes with TGF-␤ signaling. This is the
first study reporting an inhibitory effect of PAI-1 expression in
the setting of increased TGF-␤ concentration. This is significant since TGF-␤ is a known inducer of PAI-1 transcriptional
activation via Smad signaling (34, 44), a cAMP-inhibitable
reaction (11). In addition, PAI-1 activity has been also shown
to be inhibited by the anti-fibrogenic cytokine bone morphogenic protein-7 (11, 51). Thus, putative mechanisms of Glib
action on cytokine activity include inhibition of TGF-␤ signaling and enhanced bone morphogenic protein-7 formation.
There is ample evidence that HG induces PKC activity and
TGF-␤1 and PAI-1 upregulation by generation of reactive
oxygen species, following an acute exposure or chronically
after formation of advanced glycosylation end-products (6, 31,
33, 44). Accordingly, the modulation of nonenzymatic glycosylation and glycoxidation could mediate the effects of longterm treatment with Glib. Concerning an antioxidative role for
sulfonylureas, there is evidence that glicazide in vitro and in
diabetic patients acts as a free radical scavenger (28, 37).
However, Glib does not share this property (37). Besides the
results presented here, there is only a single report whereby the
renal effects of sulfonylureas were evaluated (39). In streptozotocin-diabetic rats fed high-cholesterol diets, glicazide decreased lipid peroxidation and urinary albumin excretion,
likely through its direct radical scavenging properties. However, in this setting, Glib treatment had no effect. Thus it is
highly unlikely that the Glib effects observed in this study were
attributable to reductions in glycoxidative stress.
Notably, the Glib-induced decrease in extracellular matrix
accumulation was only evident at low concentrations of the
drug. This was particularly the case for collagen I, where 0.01
M Glib treatment of HG-exposed MC produced lower accumulation than in their corresponding controls cultured in 5 mM
glucose (Figs. 1 and 3). This biphasic effect of a low vs. high
Glib concentration was not limited to matrix accumulation.
The effects on glucose transport, collagen I mRNA, and PAI-1
mRNA expression were also less evident or totally disappeared
when Glib concentration was increased by 10- to 100-fold.
This is in concert with our previous observations of enhanced
collagen synthesis and accumulation in MC acutely treated
with high concentrations (1.5 mM) of the sulfonylurea tolazamide (9). The reasons for this biphasic dose-effect are un-
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clear; however, this is not an unusual biological response. For
example, it has long been recognized that angiotensin II in low
concentrations stimulates proximal tubule Na⫹ and HCO⫺
3
transport while high concentrations are inhibitory (22), depending on whether cytosolic Ca2⫹ or PKC is activated (12).
Similarly, HMG-CoA reductase inhibitors (statins) demonstrate opposite effects on endothelial cell proliferation at low
(0.01 M) and high (1 M) concentrations by stimulating
different signaling pathways (29). Thus Glib may also enhance/repress different signaling systems depending on its
prevailing concentration.
Although MC contain SUR and functional KATP channels, it
is unknown whether these are required for the Glib effects
described in this body of work, or whether, due to the functional diversity of KATP channels, the effects of Glib are
limited to the MC. Furthermore, it is now evident that the
majority (90%) of KATP are not localized on the plasma
membrane, but intracellularly, in the endoplasmic (sarcolemmal) reticulum, mitochondria, and secretory granules (20, 46,
47). Thus it is also possible that the metabolic effects of
sulfonylureas are independent of their well-described actions
on the plasma membrane KATP. It is unknown whether the
effects of Glib may be related to the presence of ␣-endosulfine
in MC and its upregulation under HG conditions (52). Thus, if
upregulation of MC ENSA and ␣-endosulfine contributes to the
HG-induced increased extracellular matrix accumulation (10),
Glib may displace ␣-endosulfine from its receptors, acting as
an exogenous competitive inhibitor of ␣-endosulfine action.
In summary, this study demonstrates that chronic treatment
of MC with low concentrations of the sulfonylurea Glib unequivocally prevents the extracellular matrix accumulation
induced by prolonged exposure to HG via mechanisms involving inhibition of PAI-1 expression and enhanced extracellular
matrix catabolism. These, and previous observations in vivo,
raise the interesting possibility that long-term administration of
low-dose Glib may prevent glomerulosclerosis in insulin-deficient diabetes, independently of the effects of glycemia.
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